Producer
Klöckner Pentaplast (kp) Group
German specialty films company (HQ Montabaur, Rhineland-Palatinate; private equity owned — Triton Partners; ~€3B revenue); world's leading producer of pharmaceutical-grade PVC and PVdC films for blister packaging (Klöckner Pentaplast's pharma films brand 'kp'). Klöckner Pentaplast's pharmaceutical films are used in virtually all European and most global pharma blister packaging — from OTC pain relievers to prescription antibiotics and biologics. kp also produces food packaging films (deli trays, cheese packaging) and industrial films from the same manufacturing platform. Klöckner Pentaplast went through a debt restructuring in 2020 as private equity leverage proved unsustainable in the COVID year — a packaging company that makes the PVC holding most European pharmaceutical blister packs faced its own financial distress simultaneously with COVID-19 healthcare demand surge.
1
Inputs supplied
1
Goods downstream
0
Facilities
0
Stories
What they make
1 input Klöckner Pentaplast (kp) Group supplies
Click an input to see every good that depends on it, every country that produces it, and every other company in the supply chain.
Where it shows up
Goods downstream
Essential goods that depend on something Klöckner Pentaplast (kp) Group makes — pick one to see the full supply chain.
What else they do
Business segments
The company's full revenue map — where this supply-chain role fits within their broader business.
Pharma Films (kp Pharma)
50%Food & Specialty Packaging
35%Industrial & Technical Films
15%
Intelligence
What's known
Sourced claims about this company's role in supply chains — chokepoints, concentration, incidents, dual-use connections.
Concentration2024
Klöckner Pentaplast (kp) is the world's largest producer of pharmaceutical-grade PVC blister films — the material forming the pocket that holds each tablet or capsule in a push-through blister pack. kp's pharma films appear in an estimated majority of European pharmaceutical blister packs, spanning OTC pain relievers, prescription antibiotics, cardiovascular medications, and biologics. The concentration in a single PE-backed German company is a supply chain risk that European pharma regulators flagged after kp's 2020 financial restructuring: if kp faced a production halt or bankruptcy, European pharmaceutical manufacturers would have no short-term domestic alternative for pharmaceutical-grade PVC blister film at equivalent scale. The same Montabaur Germany factory whose films wrap the medications in every European pharmacy also produces the rigid PET trays holding deli meats at supermarkets — pharma-critical packaging and food packaging sharing manufacturing capacity, and both dependent on the financial stability of a PE-owned German specialty films company.
Klöckner Pentaplast Group ↗Origin2023
Klöckner Pentaplast was formed in the 1990s through the merger of Klöckner Werke (German industrial group) specialty films operations and Pentaplast (German film manufacturer), building on West Germany's postwar plastics film industry centered in Rhineland-Palatinate. kp grew through acquisitions to become the global leader in pharmaceutical PVC blister film — a market with high regulatory barriers (pharmaceutical grade film specifications, ICH compliance documentation) that rewarded scale and incumbency. Multiple private equity owners (including Triton Partners, predecessor PEs) loaded the company with acquisition debt; the COVID year's economic disruption triggered a debt restructuring in 2020 — the same year that demand for pharmaceutical packaging was surging globally as healthcare systems strained. kp's financial distress coincided with peak demand for its products, illustrating how PE leverage can create systemic supply chain fragility at critical moments.
Klöckner Pentaplast Group ↗